News Medical on MSN9 小时
GLP-1 drugs, like semaglutide, lower risk of hospitalizations for alcohol use disorderFindings suggest semaglutide and other GLP-1 agonists may significantly reduce alcohol use disorder hospitalizations, ...
BOULDER, CO / ACCESSWIRE / / Informa Market's New Hope Network and Nutrition Business Journal (NBJ) unveil a special report ...
Medpage Today on MSN13 天
Do GLP-1 Agonists Really Need to Be Stopped Before Endoscopy?Continuing GLP-1 receptor agonist medications when undergoing an endoscopic procedure appeared safe in a meta-analysis.
News Medical on MSN4 天
GLP-1 agonists linked to fewer hospitalizations in alcohol use disorder patientsA new joint study by the University of Eastern Finland and Karolinska Institutet in Sweden found that the GLP-1 agonists semaglutide and liraglutide, which are used for treating diabetes and obesity, ...
Medpage Today on MSN10 天
FDA Adds New Warning to GLP-1 DrugsThe warning affects all treatments containing GLP-1 receptor agonists, including semaglutide ( Ozempic, Wegovy, Rybelsus ), ...
GLP-1 Receptor Agonist medications, such as Ozempic, combined with exercise and nutrition, can help reduce obesity, according ...
New research, led by experts at the University of Nottingham, has found that certain types of medication used to treat ...
2024 / Informa Market's New Hope Network and Nutrition Business Journal (NBJ) unveil a special report highlighting how dietary supplements are complementary to the booming GLP-1 agonist drugs market.
Recently the U.S. Food and Drug Administration (FDA) issued updated safety warnings for all glucagon-like peptide 1 receptor ...
2024 / Informa Market's New Hope Network and Nutrition Business Journal (NBJ) unveil a special report highlighting how dietary supplements are complementary to the booming GLP-1 agonist drugs market.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈